Medtronic: beats consensus in Q1

(CercleFinance.com) - Medtronic has reported Q4 2018-19 adjusted net income (non-GAAP) that is up 4% at 1.
6 billion dollars, or 1.17 dollar per share, six cents above the consensus.

The medical equipment supplier's revenues were fairly sluggish at nearly 7.4 billion dollars, although rose 6.8% in organic terms, including an 11.2% like-for-like increase in emerging markets.

Over full-year 2018, Medtronic's management is maintaining its adjusted EPS target range of between 5.10 dollars and 5.15 dollars, although has raised its organic sales growth estimate to between 4.5% and 5%, compared with 4% to 4.5% previously.


Copyright (c) 2018 CercleFinance.com. All rights reserved.